The PatchServer brings automation to the classical patch clamp method.

Its uniqe pipette-based approach excels in high quality gigaseals, visual cell selection and fast compound application.

The PatchServer originated 2008 as a research project of our electophysiology group at NMI-TT pharmaservices to develop an automated patch clamp system for ultra fast compound applications and stem cell research.

Key features:

• optical selection of the cells to be patch clamped

• fast compound application in the ms-range

To find out more, read our recent paper:
Catch and Patch: A Pipette-Based Approach for Automating Patch Clamp That Enables Cell Selection and Fast Compound Application

Currently, the PatchServer is actively developed and used for drug screening and safety pharmacology.

A commercial version of the PatchServer is also beeing independently developed by Multichannel Systems GmbH (MCS). For more information, see the MCS PatchServer product page.